951 F. Supp. 2d 457
S.D.N.Y.2013Background
- Lead Plaintiffs (Schram) brought a securities-fraud class action on behalf of purchasers of CNinsure ADSs from March 2, 2010 to November 21, 2011, alleging CNinsure and senior officers misstated or omitted material facts about a sales‑agent equity incentive compensation plan.
- Plaintiffs allege CNinsure publicly attributed revenue growth to sales/marketing and commission-only compensation while concealing an equity-based incentive plan that (a) drove agent recruitment, (b) allowed withholding of agent compensation, and (c) reduced reported commission expenses.
- Short‑seller OLP issued reports in November–December 2010 alleging CNinsure used an equity incentive plan (involving a third party, Finestart) and that CNinsure’s disclosures and presentations corroborated that plan; CNinsure repeatedly denied the plan and characterized it as a non‑equity “scorecard.”
- ADS price declines followed the OLP reports and later November 2011 earnings press release showing rising commission expenses and slower growth; Plaintiffs allege overall ADS decline >78% and link November 21, 2011 disclosure to materialization of the concealed risk.
- Plaintiffs allege motive and opportunity: a July 2010 secondary offering raised $109.6 million (without disclosure of the equity plan) and several executives (including Hu and Lai) sold large blocks of ADSs during the class period.
- CNinsure moved to dismiss the amended complaint for failure to plead falsity, scienter, and loss causation; the court denied the motion as to Section 10(b)/Rule 10b‑5 claims and dismissed Section 20(a) for lack of service.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Falsity — were defendants’ public statements about agent compensation false or misleading? | CNinsure hid an equity incentive plan that materially affected revenues/expenses; statements claiming agents were paid only commissions were misleading. | CNinsure contends the disclosures described multiple programs and the OLP reports conflated a legitimate scorecard with disclosed equity programs; OLP unreliable. | Court: Plaintiffs plausibly alleged falsity/omissions; defendants’ competing factual account raises disputes inappropriate for dismissal. |
| Scienter — did defendants act with intent or reckless disregard? | Plaintiffs allege executives knew of or had access to information contradicting public statements, insider stock sales, suspicious acquisitions, resignations, and denial after OLP disclosure. | Defendants say allegations are boilerplate, sales were not unusual, deletions/unauthorized docs do not show scienter, and offering timing undermines motive. | Court: Taken together allegations give a strong inference of scienter (recklessness and motive/opportunity). |
| Loss causation — did the alleged fraud cause plaintiffs’ losses? | November 21, 2011 press release linked slower growth and a 40.5% rise in commission expenses to pressures on the people‑driven compensation model — the risk OLP warned about — thereby revealing the concealed risk. | Defendants argue plaintiffs fail to show a switch from equity to cash or that the press release disclosed the risk alleged; cite cases requiring clearer linkage. | Court: The press release disclosed the relevant risk (rising commissions/pressure on model); loss causation adequately pleaded at motion‑to‑dismiss stage. |
| PSLRA/Rule 9(b) particularity — did complaint specify misleading statements and supporting facts? | Plaintiffs identified specific press releases/SEC filings, statements, OLP reports and supporting documents detailing the plan mechanics. | Defendants argue reliance on OLP and internet documents is insufficient and lacks particularity. | Court: Complaint satisfies Rule 9(b) and PSLRA particularity for pleading falsity and scienter at this stage. |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading must state a plausible claim for relief)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard for complaints)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (assessing competing inferences for scienter under PSLRA)
- ATSI Communications, Inc. v. Shaar Fund, Ltd., 493 F.3d 87 (2d Cir. 2007) (securities‑fraud pleading standards and Rule 9(b) application)
- Novak v. Kasaks, 216 F.3d 300 (2d Cir. 2000) (insider knowledge/access to contrary information supports scienter)
- Basic Inc. v. Levinson, 485 U.S. 224 (1988) (fraud‑on‑the‑market presumption of reliance)
- Lentell v. Merrill Lynch & Co., 396 F.3d 161 (2d Cir. 2005) (loss causation and concealed risk analysis)